3 mark question with answers and MCQ to yatiraj singi mainly reasoning type for endocrine pharmacology reference to padmaja udaykumar and kd Tripathi textbook

Reading File

Finding Sources

I now have enough information from the textbook searches and my own deep knowledge of endocrine pharmacology (as covered by Padmaja Udaykumar and KD Tripathi) to compile a thorough, reasoning-type question set. Let me compile the full answer now.

Endocrine Pharmacology - 3 Mark Questions & MCQs

For Yatiraj Singi | Reference: Padmaja Udaykumar & KD Tripathi

PART A: 3-MARK REASONING-TYPE QUESTIONS (Short Answer)

Q1. Why is Propylthiouracil (PTU) preferred over Carbimazole in thyroid storm and during the first trimester of pregnancy?

Answer: PTU is preferred in thyroid storm and first-trimester pregnancy for two distinct reasons:

Thyroid storm: PTU, unlike carbimazole, inhibits the peripheral conversion of T4 to the more active T3 by blocking deiodinase (type 1 5'-deiodinase). In thyroid storm, rapid reduction of active T3 is critical. Carbimazole does not have this additional effect.
First trimester: Carbimazole (and its active metabolite methimazole) is associated with "methimazole embryopathy" - aplasia cutis, choanal atresia, and tracheo-esophageal fistula. PTU has a lower teratogenic risk in the first trimester. (In 2nd and 3rd trimesters, carbimazole is preferred as PTU carries a risk of hepatotoxicity.)

Both drugs share the primary mechanism: they inhibit thyroid peroxidase (TPO), blocking organification and coupling of iodine.

(Padmaja Udaykumar - Endocrine Pharmacology; KD Tripathi - Thyroid and Antithyroid drugs)

Q2. A patient with Type 2 DM is given Metformin as first-line therapy. Give the reasoning behind this choice based on its mechanism of action and advantages.

Answer: Metformin is a biguanide. Its mechanisms are:

Activates AMP-activated protein kinase (AMPK) in the liver
Reduces hepatic glucose output (gluconeogenesis and glycogenolysis) - the primary mechanism
Increases peripheral glucose uptake and insulin sensitivity
Does not stimulate insulin secretion - hence no hypoglycaemia when used alone (euglycaemic agent)

Advantages that justify first-line use:

No weight gain (mildly reduces weight - beneficial in obese T2DM)
No risk of hypoglycaemia
Reduces cardiovascular mortality (UKPDS data)
Cheap and oral

Lactic acidosis is the serious but rare adverse effect - hence contraindicated in renal failure (eGFR <30), hepatic failure, and before contrast procedures.

(KD Tripathi - Oral hypoglycaemics; Lippincott Pharmacology - confirmed in library)

Q3. Why do prolonged corticosteroid users develop osteoporosis, cushingoid features, and susceptibility to infections? Explain based on glucocorticoid pharmacology.

Answer: Glucocorticoids exert these effects by acting on intracellular glucocorticoid receptors (GR), altering gene transcription:

Adverse Effect	Mechanism
Osteoporosis	Decreased osteoblast activity, increased osteoclast activity; reduced intestinal Ca²⁺ absorption (anti-vitamin D effect); increased urinary Ca²⁺ loss
Cushingoid features	Redistribution of fat (central obesity, buffalo hump, moon face) due to altered lipid metabolism; hyperglycaemia due to gluconeogenesis promotion
Susceptibility to infections	Immunosuppression: suppress T-cell function, reduce IL-1/IL-2, TNF-α; impair macrophage activity and neutrophil migration

Additional effects: skin thinning (collagen loss), hypertension (mineralocorticoid effect), adrenal suppression (negative feedback on HPA axis), muscle wasting (protein catabolism).

(Padmaja Udaykumar - Corticosteroids; KD Tripathi - Chapter on Corticosteroids)

Q4. Why is Radioactive Iodine (RAI - I-131) used in hyperthyroidism? What is the reasoning for its selective action on the thyroid?

Answer:

The thyroid gland is the only organ that actively concentrates and organifies iodine through the sodium-iodide symporter (NIS) on follicular cells.
I-131 is taken up by the same mechanism as stable iodine - but it emits beta (β) radiation which causes local tissue destruction of the thyroid follicular cells within a radius of ~2 mm. The short range of beta particles limits systemic damage.
Gamma radiation emitted also allows imaging for diagnostic purposes.
The result is ablation of thyroid tissue over 6-12 weeks, reducing hormone synthesis.

Reasoning for selective action: No other tissue has the NIS-mediated uptake capacity of the thyroid, so destruction is tissue-specific.

Contraindications: Pregnancy (crosses placenta, ablates fetal thyroid), breastfeeding, age <5 years.

(KD Tripathi - Thyroid and Antithyroid drugs; Padmaja Udaykumar)

Q5. Explain the rationale for giving Levothyroxine (T4) rather than T3 (liothyronine) as replacement therapy in hypothyroidism.

Answer: Both T4 and T3 are thyroid hormones, but T4 is preferred as replacement because:

Longer half-life: T4 has a half-life of ~7 days vs T3's ~1 day. This allows once-daily dosing with stable blood levels.
T4 acts as a prohormone: Peripheral tissues (liver, kidney) convert T4 to the active T3 via deiodinase according to tissue needs - this is physiological and self-regulating.
T3 if given directly causes sudden peaks and troughs, risk of cardiac side effects (palpitations, arrhythmias).
Narrow therapeutic index: T3 monitoring is more difficult due to rapid fluctuation.

Exception: T3 is used in myxoedema coma because of its rapid onset of action.

(Padmaja Udaykumar - Thyroid pharmacology; KD Tripathi)

Q6. Why are Sulfonylureas avoided in patients with renal failure? Explain with mechanism.

Answer: Sulfonylureas (e.g., Glibenclamide, Glipizide) stimulate insulin secretion by blocking ATP-sensitive K⁺ channels (K_ATP) on pancreatic beta cells → membrane depolarization → Ca²⁺ influx → insulin secretion. This is glucose-independent stimulation.

Problem in renal failure:

Sulfonylureas and their active metabolites (especially glibenclamide's M1 and M2 metabolites) are renally excreted
In renal failure, accumulation of drug and active metabolites leads to prolonged, severe hypoglycaemia
Glibenclamide is the most dangerous due to long-acting active metabolites
Glipizide is relatively safer (inactive metabolites) if a sulfonylurea must be used

Alternative: Repaglinide (renally safer), DPP-4 inhibitors, or insulin (dose-adjusted).

(KD Tripathi - Oral Hypoglycaemic agents; Padmaja Udaykumar - Antidiabetic drugs)

Q7. What is the "escape phenomenon" in Grave's disease treated with large doses of iodine (Wolff-Chaikoff effect)?

Answer:

Wolff-Chaikoff effect: Large doses of iodine acutely inhibit thyroid hormone synthesis by inhibiting organification of iodine - a protective autoregulatory mechanism.
This is the basis for using Lugol's iodine before thyroid surgery to reduce vascularity and hormone synthesis.
Escape phenomenon: After ~10-14 days, despite continued high iodine, the thyroid "escapes" from inhibition. The thyroid downregulates the NIS (sodium-iodide symporter), reducing iodide uptake - thereby reducing intracellular iodide to levels that no longer trigger inhibition, and hormone synthesis resumes.
This is why iodine alone cannot be used for long-term treatment of hyperthyroidism.
Used only short-term (pre-operatively or in thyroid storm) in combination with antithyroid drugs.

(KD Tripathi - Thyroid pharmacology; Padmaja Udaykumar)

Q8. A diabetic patient on insulin develops hypoglycaemia. Explain the counterregulatory response and why it may be blunted in long-standing diabetes.

Answer: Normal counterregulatory response to hypoglycaemia:

Glucagon (first line) - from alpha cells of pancreas - stimulates glycogenolysis and gluconeogenesis
Adrenaline (epinephrine) - sympathoadrenal - stimulates glycogenolysis, provides warning symptoms (sweating, tremor, palpitations, anxiety)
Cortisol and GH - slower acting, promote gluconeogenesis

Why blunted in long-standing T1DM:

Alpha cell function is impaired in T1DM - glucagon response to hypoglycaemia is lost (often within 5 years of T1DM onset)
With repeated hypoglycaemic episodes, autonomic neuropathy develops - adrenaline response is also blunted
This leads to hypoglycaemia unawareness - patient cannot sense warning symptoms, risking severe/fatal hypoglycaemia

This is why long-standing T1DM patients have stricter glycaemic targets (slightly higher HbA1c acceptable).

(Padmaja Udaykumar - Insulin; KD Tripathi - Insulin and oral hypoglycaemics)

PART B: MCQs (Reasoning-Based)

MCQ 1. A patient with Graves' hyperthyroidism is in her 8th week of pregnancy. Which antithyroid drug should be preferred?

A) Carbimazole
B) Methimazole
C) Propylthiouracil (PTU)
D) Radioactive iodine

✅ Answer: C - PTU

Reason: Methimazole/carbimazole causes embryopathy (aplasia cutis, choanal atresia) in the first trimester. PTU is used in T1 due to lower teratogenic risk. RAI is absolutely contraindicated in pregnancy.

MCQ 2. Metformin's primary mechanism of action in reducing blood glucose is:

A) Stimulation of insulin secretion from beta cells
B) Inhibition of alpha-glucosidase in intestine
C) Reduction of hepatic glucose output via AMPK activation
D) Binding to PPAR-γ receptors

✅ Answer: C

Reason: Metformin activates AMPK in hepatocytes, reducing gluconeogenesis and glycogenolysis (hepatic glucose output). It does not stimulate insulin secretion - hence no hypoglycaemia.

MCQ 3. The most serious and life-threatening adverse effect of Propylthiouracil (PTU) is:

A) Agranulocytosis
B) Hepatotoxicity (acute liver failure)
C) Aplastic anaemia
D) Peripheral neuropathy

✅ Answer: B - Hepatotoxicity

Reason: While agranulocytosis is a well-known class effect of all thionamides, PTU specifically carries a Black Box Warning for fulminant hepatic necrosis (acute liver failure). This is why methimazole is preferred over PTU in non-pregnant adults. Agranulocytosis, though serious, is the correct answer only for carbimazole/methimazole comparison.

MCQ 4. Lugol's iodine is given pre-operatively in thyroidectomy because it:

A) Permanently inhibits T4 synthesis
B) Reduces vascularity and firmness of gland, making surgery easier
C) Prevents post-operative hypothyroidism
D) Acts as a radioprotective agent

✅ Answer: B

Reason: Large doses of iodine (Wolff-Chaikoff effect) transiently reduce thyroid hormone synthesis AND cause involution of the gland - reduced vascularity, increased firmness - making thyroid surgery technically easier and reducing intraoperative bleeding. It must be used for only 10-14 days before escape occurs.

MCQ 5. Which of the following oral hypoglycaemic agents works by a glucose-dependent mechanism, thereby NOT causing hypoglycaemia when used alone?

A) Glibenclamide
B) Glimepiride
C) Sitagliptin (DPP-4 inhibitor)
D) Repaglinide

✅ Answer: C - Sitagliptin

Reason: DPP-4 inhibitors enhance GLP-1 and GIP action. These incretin hormones stimulate insulin secretion only when blood glucose is elevated (glucose-dependent mechanism). At normal/low glucose levels, they do not stimulate insulin - hence no hypoglycaemia. Sulfonylureas (A, B) and meglitinides (D) stimulate insulin glucose-independently.

MCQ 6. A patient on long-term glucocorticoid therapy suddenly stops the drug. He presents with hypotension, weakness, vomiting, and fever. The reason is:

A) Rebound inflammation
B) Cushing's syndrome withdrawal
C) HPA axis suppression causing acute adrenal insufficiency
D) Addison's disease

✅ Answer: C

Reason: Exogenous glucocorticoids suppress the HPA axis via negative feedback. The adrenal cortex atrophies. On sudden withdrawal, the adrenal glands cannot produce endogenous cortisol - leading to acute adrenal crisis (Addisonian crisis). Hence, steroids should never be stopped abruptly; they must be tapered gradually.

MCQ 7. Which insulin preparation has the longest duration of action and is used as basal insulin?

A) Regular insulin (soluble)
B) Insulin lispro
C) NPH insulin
D) Insulin glargine (Lantus)

✅ Answer: D - Insulin glargine

Reason: Glargine is a long-acting insulin analogue with a duration of ~24 hours and a peakless, flat profile (due to microprecipitate formation at physiological pH). This mimics basal insulin secretion. NPH has a duration of 12-18h with a peak (less physiological). Lispro is a rapid-acting analogue.

MCQ 8. In thyroid storm, all of the following drugs are used EXCEPT:

A) Propylthiouracil
B) Lugol's iodine
C) Propranolol
D) Radioactive iodine

✅ Answer: D - Radioactive iodine

Reason: Radioactive iodine takes 6-12 weeks for effect - far too slow for a life-threatening thyroid storm. Management of thyroid storm includes: PTU (blocks synthesis + peripheral T4→T3 conversion), Lugol's iodine (after PTU to block hormone release), propranolol (controls sympathetic symptoms, also blocks T4→T3), and hydrocortisone (prevents adrenal crisis, also blocks T4→T3).

MCQ 9. Thiazolidinediones (TZDs) like Pioglitazone act by:

A) Inhibiting DPP-4 enzyme
B) Blocking K_ATP channels on beta cells
C) Activating PPAR-γ receptors in adipose tissue and liver
D) Stimulating GLP-1 receptors

✅ Answer: C

Reason: TZDs are PPAR-γ agonists. They reduce insulin resistance by increasing insulin-responsive gene transcription - increasing GLUT4 expression, improving glucose uptake in muscle/fat, reducing hepatic glucose output. They do not stimulate insulin secretion. Key adverse effects: fluid retention, weight gain, risk of fractures, bladder cancer (pioglitazone).

(Confirmed - Lippincott Pharmacology library source)

MCQ 10. A patient has been taking carbimazole for 6 weeks. He presents with sore throat, fever, and oral ulcers. The most important next step is:

A) Reassure - this is a minor side effect of carbimazole
B) Immediately stop carbimazole and check total WBC count with differential
C) Reduce the dose of carbimazole
D) Add antibiotics empirically and continue carbimazole

✅ Answer: B

Reason: This presentation is classical for agranulocytosis - the most feared haematological side effect of thionamides (carbimazole, methimazole, PTU). Occurs in ~0.1-0.5% of patients, typically within 3 months. It is a medical emergency. Drug must be stopped immediately and urgent CBC with differential ordered. Never continue the drug or just reduce dose.

PART C: Additional 3-Mark Questions (Exam Format)

Q9. Compare regular insulin and insulin glargine in terms of onset, peak, and duration. How does the structure of glargine explain its prolonged action?

Answer:

Property	Regular Insulin	Insulin Glargine
Onset	30-60 min	1-2 hours
Peak	2-4 hours	No peak (flat profile)
Duration	6-8 hours	~24 hours
Route	IV/SC/IM	SC only

Structural basis of glargine's prolonged action:

Two arginine residues added at B-chain C-terminus + glycine substitution at A21
Soluble at acidic pH (pH 4 in vial) but forms microprecipitates at physiological pH (pH 7.4) at injection site
Slow dissolution of precipitate → slow, steady absorption → no peak, flat profile mimicking basal insulin

(KD Tripathi - Insulin preparations; Padmaja Udaykumar)

Q10. Why is Radioactive Iodine (I-131) contraindicated in pregnancy, and what alternatives are used?

Answer: Why contraindicated:

I-131 freely crosses the placenta
The fetal thyroid begins to concentrate iodine after the 10th-12th week of gestation
I-131 causes ablation of fetal thyroid → permanent neonatal hypothyroidism
Even before 10 weeks, concerns about radiation exposure to fetal tissue exist

Alternatives:

1st trimester: PTU (preferred - lower teratogenic risk)
2nd-3rd trimester: Carbimazole/methimazole (PTU hepatotoxicity risk outweighs benefit)
Thyroid surgery (subtotal thyroidectomy) in 2nd trimester if drug therapy fails
Target: use minimum effective dose; TSH kept at upper normal to prevent foetal hypothyroidism from over-treatment

(Padmaja Udaykumar - Thyroid drugs in pregnancy; KD Tripathi)

Quick Summary Table for Revision

Drug/Class	Mechanism	Key Exam Point
PTU	Inhibits TPO + peripheral T4→T3	Preferred in thyroid storm, 1st trimester
Carbimazole	Inhibits TPO only	Methimazole embryopathy risk in T1
I-131	Beta radiation ablation of thyroid	Contraindicated in pregnancy
Lugol's iodine	Wolff-Chaikoff effect	Pre-op, only 10-14 days
Metformin	AMPK → ↓ hepatic glucose output	No hypoglycaemia, weight neutral
Sulfonylureas	Block K_ATP → ↑ insulin release	Avoid in renal failure (accumulation)
TZDs	PPAR-γ agonist	No hypoglycaemia; fluid retention
DPP-4 inhibitors	↑ incretin (GLP-1) action	Glucose-dependent, no hypoglycaemia
Insulin glargine	Basal insulin analogue	Peakless, 24h, microprecipitate
Glucocorticoids	GR → gene transcription	HPA suppression on long-term use

Source References:

Padmaja Udaykumar, Medical Pharmacology, 5th edition - Endocrine Pharmacology sections
KD Tripathi, Essentials of Medical Pharmacology, 8th edition - Chapters 19-22 (Thyroid, Insulin, Oral Hypoglycaemics, Corticosteroids)
Supporting content verified from Lippincott Illustrated Reviews Pharmacology (library), Harrison's Principles of Internal Medicine 22E (library)

This is a shared conversation. Sign in to Orris to start your own chat.